HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Veronesi Selected Research

Breast Neoplasms (Breast Cancer)

12/2022CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer.
7/2021Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
12/2020Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study.
1/2020Immediate breast reconstruction with latissimus dorsi flap for patients with local recurrence of breast cancer.
12/2017Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery.
1/2016Oncological results of oncoplastic breast-conserving surgery: Long term follow-up of a large series at a single institution: A matched-cohort analysis.
2/2015Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.
3/2014Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials.
12/2013The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study.
6/2013Evaluation of fat grafting safety in patients with intraepithelial neoplasia: a matched-cohort study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Veronesi Research Topics

Disease

40Breast Neoplasms (Breast Cancer)
12/2022 - 08/2000
23Neoplasms (Cancer)
12/2022 - 08/2000
7Neoplasm Metastasis (Metastasis)
12/2022 - 11/2001
5Carcinoma (Carcinomatosis)
09/2009 - 07/2001
2Residual Neoplasm
02/2015 - 12/2003
1Carcinogenesis
12/2022
1Surgical Wound
12/2018
1Hemangiosarcoma (Angiosarcoma)
05/2015
1Necrosis
02/2012
1Infections
09/2009
1Male Breast Neoplasms (Male Breast Cancer)
12/2007
1Lymphatic Metastasis
03/2007
1Contracture
01/2006
1Calcinosis
12/2005
1Noninfiltrating Intraductal Carcinoma (DCIS)
12/2005
1Fistula
01/2003
1Pancreatic Fistula (Pancreatic Fistulas)
01/2003
1Postmenopausal Osteoporosis
09/2001

Drug/Important Bio-Agent (IBA)

9Estrogen ReceptorsIBA
03/2014 - 08/2000
8Progesterone Receptors (Progesterone Receptor)IBA
03/2013 - 08/2000
5Phenobarbital (Luminal)FDA Link
03/2014 - 10/2010
3Biomarkers (Surrogate Marker)IBA
12/2022 - 11/2004
2Hormones (Hormone)IBA
12/2022 - 08/2000
2human ERBB2 proteinIBA
02/2012 - 10/2010
2Letrozole (Femara)FDA LinkGeneric
09/2007 - 09/2006
2AnthracyclinesIBA
09/2006 - 11/2001
2Cisplatin (Platino)FDA LinkGeneric
10/2003 - 11/2001
2Vinorelbine (Navelbine)FDA LinkGeneric
10/2003 - 11/2001
2Fluorouracil (Carac)FDA LinkGeneric
10/2003 - 11/2001
1CarbonIBA
12/2022
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2022
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2022
1Serine (L-Serine)FDA Link
12/2022
1Methotrexate (Mexate)FDA LinkGeneric
12/2022
1AntimetabolitesIBA
12/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2022
1Trastuzumab (Herceptin)FDA Link
12/2017
1PlasticsIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
05/2015
1Sex Hormone-Binding GlobulinIBA
03/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2014
1C-Reactive ProteinIBA
03/2014
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2013
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2007
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2007
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2006
1Docetaxel (Taxotere)FDA Link
09/2006
1Triptorelin Pamoate (Trelstar)FDA Link
09/2006
1Taxoids (Taxanes)IBA
09/2006
1Cyclin-Dependent Kinase Inhibitor p27IBA
06/2002
1Raloxifene Hydrochloride (Evista)FDA Link
09/2001
1Indicators and Reagents (Reagents)IBA
03/2001
1Estrogens (Estrogen)FDA Link
08/2000

Therapy/Procedure

10Drug Therapy (Chemotherapy)
12/2022 - 08/2000
10Therapeutics
12/2022 - 09/2001
9Radiotherapy
07/2021 - 07/2001
7Mastectomy (Mammectomy)
12/2018 - 10/2003
6Segmental Mastectomy (Lumpectomy)
11/2019 - 07/2001
2Mammaplasty (Breast Reconstruction)
01/2020 - 06/2013
2Conservative Treatment
03/2009 - 01/2006
2ViFuP protocol
10/2003 - 11/2001
1Maintenance Chemotherapy
12/2022
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
07/2021
1Neoadjuvant Therapy
02/2015
1Role Playing (Playing, Role)
06/2013
1Prophylactic Mastectomy
02/2012
1Prostheses and Implants (Prosthesis)
09/2009
1Combined Modality Therapy
06/2008
1Contraindications
12/2007
1Breast Implants (Breast Implant)
01/2006
1Pancreaticojejunostomy
01/2003
1Pancreatectomy
01/2003
1Aftercare (After-Treatment)
09/2001